Alpha 2.0
Login Register
» Authors » Sophie Riviere

Sophie Riviere

Explore the profile of Sophie Riviere including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 54
Citations 926
Followers 0
Related Specialties
General Medicine
Rheumatology
Allergy & Immunology
Top 10 Co-Authors
Sophie Dupuis-Girod
Evelyne Decullier
Alain Le Quellec
Philippe Guilpain
Gregory Pugnet
Nathalie Tieulie
Loic Guillevin
David Saadoun
Luc Mouthon
Brigitte Gilbert-Dussardier
Published In
Rheumatology (Oxford)
Autoimmun Rev
PLoS One
Orphanet J Rare Dis
Ann Pathol
Affiliations
Soon will be listed here.
Recent Articles
1.
Effect of oral nintedanib vs placebo on epistaxis in hereditary hemorrhagic telangiectasia: the EPICURE multicenter randomized double-blind trial
Hermann R, Grobost V, Le-Guillou X, Lavigne C, Parrot A, Riviere S, et al.
Angiogenesis . 2024 Dec; 28(1):9. PMID: 39718659
Epistaxis greatly affects patients with hereditary hemorrhagic telangiectasia (HHT). Although few systemic treatment exist, nintedanib, is a good candidate thanks to its anti-angiogenic activity. Our main objective was to evaluate...
2.
A large deletion in a non-coding regulatory region leads to NFKB1 haploinsufficiency in two adult siblings
Fusaro M, Coustal C, Barnabei L, Riller Q, Heller M, Ho Nhat D, et al.
Clin Immunol . 2024 Feb; 261:110165. PMID: 38423196
Mutations in NFkB pathway genes can cause inborn errors of immunity (IEI), with NFKB1 haploinsufficiency being a significant etiology for common variable immunodeficiency (CVID). Indeed, mutations in NFKB1 are found...
3.
Chronological interplay, clinical features, and treatments among patients with cancer and primary Sjögren's syndrome
Viel P, Henry K, Morel J, Jacot W, Jorgensen C, Riviere S, et al.
Cancer Immunol Immunother . 2023 Nov; 72(12):4309-4322. PMID: 37938369
Objective: While the incidence and type of blood malignancies are well documented amid primary Sjögren's syndrome patients (pSS), data focusing on solid neoplasms are more conflicting. We aimed to describe...
4.
High prevalence of malnutrition in systemic sclerosis: Results from a French monocentric cross-sectional study
Rivet V, Riviere S, Goulabchand R, Suzon B, Henneton P, Partouche L, et al.
Nutrition . 2023 Oct; 116:112171. PMID: 37837826
Objectives: Systemic sclerosis (SSc) can cause malnutrition due to frequent gastrointestinal involvement. However, prevalence of malnutrition in SSc is poorly known. The aim of this study was to evaluate the...
5.
Prevalence of anti-neutrophil cytoplasmic antibody-associated vasculitis in the south of France, using the capture-recapture method
Rubenstein E, Henneton P, Riviere S, Casanova M, Broner J, Arnaud E, et al.
Rheumatology (Oxford) . 2023 Oct; 63(6):1552-1559. PMID: 37819770
Objectives: This study aimed to estimate the prevalence of ANCA-associated vasculitis (AAV). That is, granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA), in Southern France...
6.
Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial
Dupuis-Girod S, Riviere S, Lavigne C, Fargeton A, Gilbert-Dussardier B, Grobost V, et al.
J Intern Med . 2023 Aug; 294(6):761-774. PMID: 37592715
Background: Bevacizumab-a humanized monoclonal antibody-has been widely used to treat patients with hereditary hemorrhagic telangiectasia (HHT), but no randomized trial has yet been conducted. Methods: This study is a double-blind...
7.
Long-term home parenteral nutrition in systemic sclerosis-related intestinal failure is feasible but unveils occult cardiac disease
Suzon B, Riviere S, Schiffmann A, Rivet V, Flori N, Guilpain P, et al.
Nutrition . 2023 Mar; 110:112009. PMID: 36965242
Objective: The aim of this study was to compare safety and efficacy of long-term home parenteral nutrition between patients with systemic sclerosis and intestinal failure (IF) and controls with IF...
8.
Seven cases of hereditary haemorrhagic telangiectasia-like hepatic vascular abnormalities associated with pathogenic variants
Guilhem A, Dupuis-Girod S, Espitia O, Riviere S, Seguier J, Kerjouan M, et al.
J Med Genet . 2023 Feb; 60(9):905-909. PMID: 36813543
Background: loss of function is associated with type 2 capillary malformation-arteriovenous malformation syndrome, an autosomal dominant vascular disorder. The phenotype partially overlaps with hereditary haemorrhagic telangiectasia (HHT) due to epistaxis,...
9.
Intravenous Immunoglobulins Tapering and Withdrawal in Systemic Capillary Leak Syndrome (Clarkson Disease)
Moyon Q, De Chambrun M, Gousseff M, Mathian A, Hie M, Urbanski G, et al.
J Allergy Clin Immunol Pract . 2022 Jul; 10(11):2889-2895. PMID: 35870726
Background: The systemic capillary leak syndrome (SCLS), also known as Clarkson disease, is a very rare condition characterized by recurrent life-threatening episodes of vascular hyperpermeability in the presence of a...
10.
Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT
Le T, Martinent G, Dupuis-Girod S, Parrot A, Contis A, Riviere S, et al.
Orphanet J Rare Dis . 2022 Jul; 17(1):281. PMID: 35854330
Background: Hereditary hemorrhagic telangiectasia (HHT) disease is a rare genetic disorder with symptoms and complications that can significantly affect patients' daily lives. To date, no scale has been validated to...